Nagashree Seetharamu

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 14

Top Topics

Tyrosine Kinase

Acute Lymphoblastic Leukemia

Small Cell Lung Cancer

Top Venues

Lung cancer management

Cancer control : journal of the Moffitt Cancer Center

Cancer management and research

OncoTargets and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Daniel M Koffler, Jacob Eckstein, Joseph Herman, Diana Martins-Welch, Nagashree Seetharamu, Maged Ghaly, Nina Kohn, Louis Potters, Douglas Frank, Kevin Sullivan, Bhupesh Parashar
Efficacy of ketamine mouthwash in the management of oral and pharyngeal toxicity associated with head and neck chemoradiotherapy: protocol for a phase II, Simon's two-stage trial. BMJ open 13 (4) (2023)
Margaret Locke, Nina Kohn, Nagashree Seetharamu
Efficacy and tolerability of a low dose weekly paclitaxel, carboplatin and cetuximab (PCC) regimen for metastatic or unresectable head and neck squamous cell carcinomas. Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery (2023)
Madison Fraser, Nagashree Seetharamu, Matthew Diamond, Chung-Shien Lee
Profile of Capmatinib for the Treatment of Metastatic Non-Small Cell Lung Cancer (NSCLC): Patient Selection and Perspectives. Cancer management and research 15 (2023)
Coral Olazagasti, Nagashree Seetharamu
Disparities in Lung Cancer Screening in Puerto Rico: A United States Colony with Unequal Benefits. Cancer control : journal of the Moffitt Cancer Center 28 (2022)
Melissa Neumann, Neal Murphy, Nagashree Seetharamu
Impact of Family and Social Network on Tobacco Cessation Amongst Cancer Patients. Cancer control : journal of the Moffitt Cancer Center 28 (2022)
Michael R Shafique, Terrence L Fisher, Elizabeth E Evans, John E Leonard, Desa Rae E Pastore, Crystal L Mallow, Ernest Smith, Vikas Mishra, Andreas Schröder, Kevin M Chin, J Thaddeus Beck, Megan A Baumgart, Ramaswamy Govindan, Nashat Y Gabrail, Alexander I Spira, Nagashree Seetharamu, Yanyan Lou, Aaron S Mansfield, Rachel E Sanborn, Jonathan Wade Goldman, Maurice Zauderer
A Phase Ib/II Study of Pepinemab in Combination with Avelumab in Advanced Non-Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (13) (2021)
Richard Lewis Martin, Michael J Grant, Stephen M Kimani, Shonali Midha, Jori May, Rushad Patell, Emily Collier, David Furfaro, Charles Bodine, Leo E Reap, Nikesh N Shah, Jess DeLaune, Samuel B Brusca, Coral Olazagasti, Shreya Goyal, Samuel M Rubinstein, Nausheen Hakim, Shuai Qin, Sabrina L Browning, Laura Sena, Jill Gilbert, Mario A Davidson, Christine M Lovly, Nagashree Seetharamu, Deepa Rangachari, Martina Murphy, Monica S Chatwal, Rita Paschal, Elizabeth Henry, Frances Collichio, Jennifer R Green
Forming the Hematology-Oncology Collaborative Videoconferencing (CO-VID) Learning Initiative: Experiential Lessons Learned From a Novel Trainee-Led Multidisciplinary Virtual Learning Platform. JCO oncology practice (2021)
Chung-Shien Lee, Emily Miao, Kasturi Das, Nagashree Seetharamu
Clinical efficacy with dabrafenib and trametinib in a T599_V600insT poorly differentiated metastatic thyroid carcinoma. BMJ case reports 14 (8) (2021)
Coral Olazagasti, Nagashree Seetharamu
Disparities in lung cancer screening rates among the Hispanic/LatinX population. Lung cancer management 10 (3) (2021)
Chung-Shien Lee, Matthew Milone, Nagashree Seetharamu
Osimertinib in EGFR-Mutated Lung Cancer: A Review of the Existing and Emerging Clinical Data. OncoTargets and therapy 14 (2021)
Chung-Shien Lee, Sandhya Sharma, Emily Miao, Cheryl Mensah, Kevin Sullivan, Nagashree Seetharamu
A Comprehensive Review of Contemporary Literature for Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer and Their Toxicity. Lung Cancer (Auckland, N.Z.) 11 (2020)
Coral Olazagasti, Carolina Bernabe, Nagashree Seetharamu
Lung cancer screening guidelines are clear but are they being followed? Lung cancer management 9 (4) (2020)
James Newman, Isabel Preeshagul, Nina Kohn, Craig Devoe, Nagashree Seetharamu
Simple parameters to solve a complex issue: predicting response to checkpoint inhibitor therapy in lung cancer. Lung cancer management 10 (2) (2020)
Karie Runcie, Daniel R Budman, Veena John, Nagashree Seetharamu
Bi-specific and tri-specific antibodies- the next big thing in solid tumor therapeutics. Molecular medicine (Cambridge, Mass.) 24 (1) (2018)